FDA Approves Aleve PM
FDA Approves Aleve PM (diphenhydramine hydrochloride and naproxen sodium)
January 16, 2014 -- The The United States Food and Drug Administration (FDA) has approved Aleve PM (diphenhydramine hydrochloride and naproxen sodium), an over-the-counter antihistamine and nonsteroidal anti-inflammatory drug (NSAID) combination for the relief of occasional sleeplessness associated with minor aches and pains.
Aleve PM contains the nonsteroidal anti-inflammatory drug (NSAID) naproxen sodium (contained in Aleve) which has been known to cause allergic reactions and stomach bleeding. It also contains the antihistamine diphenhydramine hydrochloride (contained in Benadryl) which can cause drowsiness.
Always read the directions for use carefully and check with your doctor or pharmacist if you have any concerns.
Aleve PM is distributed by Bayer HealthCare LLC, Consumer Care in Morristown, NJ.
Posted: January 2014
Aleve PM (diphenhydramine hydrochloride and naproxen sodium) FDA Approval History
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.
